West Michael A, Moore Ernest E, Shapiro Michael B, Nathens Avery B, Cuschieri Joseph, Johnson Jeffrey L, Harbrecht Brian G, Minei Joseph P, Bankey Paul E, Maier Ronald V
Department of Surgery, University of California, San Francisco, San Francisco, California 94110, USA.
J Trauma. 2008 Dec;65(6):1511-9. doi: 10.1097/TA.0b013e318184ee35.
When the clinical decision to treat a critically ill patient with antibiotics has been made, one must attempt to identify the site of infection based on clinical signs and symptoms, laboratory or diagnostic radiology studies. Identification of site requires, examination of patient, inspection of all wounds, chest radiograph, and calculation of clinical pulmonary infection score if ventilated, obtaining blood cultures, urinalysis, and line change if clinical suspicion of central venous catheter (CVC) source. If it is impossible to identify site, obtain cultures from all accessible suspected sites and initiate empiric, broad spectrum antibiotics. If likely site can be identified answer these questions: Is intra-abdominal site suspected? Is pulmonary source of infection suspected? Is skin, skin structure or soft tissue site suspected? If yes, does the patient have clinical signs suspicion for necrotizing soft tissue infection (NSTI)? Is a CVC infection suspected? Risk factors for more complicated infections are discussed and specific antibiotic recommendations are provided for each type and severity of clinical infection. Decision to continue, discontinue and/or alter antibiotic/antimicrobial treatment should be based on the clinical response to treatment, diagnostic or interventional findings, and culture and sensitivity data, bearing in mind that not all patients with infections will have positive cultures because of limitations of specimen handling, microbiology laboratory variations, time between specimen acquisition and culture, or presence of effective antibiotics at the time that specimens were obtained. It should also be noted that not all patients with increased temperature/WBC have an infection. Discontinuation of antibiotics is appropriate if cultures and other diagnostic studies are negative.
当决定对重症患者使用抗生素进行治疗时,必须根据临床体征和症状、实验室检查或诊断性放射学检查来确定感染部位。确定感染部位需要对患者进行检查、查看所有伤口、拍摄胸部X光片,如果患者正在接受通气治疗,还需计算临床肺部感染评分,进行血培养、尿液分析,若临床怀疑中心静脉导管(CVC)是感染源则更换导管。如果无法确定感染部位,需从所有可及的可疑部位采集培养样本,并开始使用经验性广谱抗生素。如果能够确定可能的感染部位,回答以下问题:是否怀疑腹腔内感染?是否怀疑肺部感染源?是否怀疑皮肤、皮肤结构或软组织感染?如果是,患者是否有坏死性软组织感染(NSTI)的临床体征?是否怀疑CVC感染?讨论更复杂感染的危险因素,并针对每种临床感染类型和严重程度提供具体的抗生素使用建议。抗生素/抗菌药物治疗的继续、停用和/或调整决策应基于治疗的临床反应、诊断或干预结果以及培养和药敏数据,同时要记住,由于标本处理的局限性、微生物实验室差异、标本采集与培养之间的时间间隔或采集标本时存在有效的抗生素,并非所有感染患者的培养结果都会呈阳性。还应注意,并非所有体温升高/白细胞增多的患者都有感染。如果培养和其他诊断检查结果为阴性,则停用抗生素是合适的。